Hansoh Pharmaceutical Group Company Limited (HKG: 3692)

Hansoh Pharmaceutical Group Company Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21,745	22,435	17,615	14,702	4,285	8,238
Short-Term Investments	1,431	1,937	1,471	1,882	9,241	3,588
Trading Asset Securities	320.88	512.41	2,544	2,357	200	2,772
Cash & Short-Term Investments	23,498	24,884	21,631	18,941	13,726	14,599
Cash Growth	-0.16%	15.04%	14.20%	37.99%	-5.98%	317.51%
Accounts Receivable	2,938	3,214	3,578	3,676	3,127	2,246
Other Receivables	-	80.89	47.42	52.74	82.82	32.72
Receivables	2,938	3,295	3,626	3,729	3,210	2,279
Inventory	599.51	575.78	447.89	410.13	298.73	414.35
Prepaid Expenses	-	3.83	1.73	0.97	2.11	0.6
Other Current Assets	370.89	124.83	125.6	98.05	48.61	155.72
Total Current Assets	27,406	28,883	25,832	23,179	17,286	17,448
Property, Plant & Equipment	3,308	3,280	3,450	3,475	2,304	1,928
Long-Term Investments	743.41	684.71	653.65	394.97	28.39	-
Other Intangible Assets	196.62	177.42	33.42	17.04	9.89	4.57
Other Long-Term Assets	17.52	13.93	33.29	93.4	1,164	194.71
Total Assets	31,672	33,039	30,002	27,160	20,792	19,575
Accounts Payable	174.56	163.76	222.3	248.33	124.38	192.85
Accrued Expenses	2,055	1,969	1,925	2,201	1,877	1,459
Current Portion of Long-Term Debt	40.26	4,183	-	-	-	-
Current Portion of Leases	15.28	16.09	15.54	9.97	11.04	3.65
Current Income Taxes Payable	5.38	85.65	90.94	134.2	11.4	40.68
Current Unearned Revenue	18.16	38.47	25.1	22.2	195.69	40.47
Other Current Liabilities	1,124	406.37	340.93	408.47	469.92	4,504
Total Current Liabilities	3,433	6,863	2,620	3,024	2,690	6,240
Long-Term Debt	-	39.74	4,283	3,743	-	-
Long-Term Leases	64.14	64.71	79.57	74.92	81.71	5.78
Long-Term Deferred Tax Liabilities	250.75	255.02	350.66	266.75	121.81	284.77
Other Long-Term Liabilities	21.75	21.99	22.46	22.93	23.4	-
Total Liabilities	3,769	7,244	7,355	7,131	2,916	6,531
Common Stock	0.05	0.05	0.05	0.05	0.05	0.05
Additional Paid-In Capital	14,000	14,096	13,932	14,024	14,009	10,837
Retained Earnings	13,362	11,405	8,780	6,910	4,578	2,009
Treasury Stock	-13.6	-108.63	-28.03	-57.97	-	-
Comprehensive Income & Other	555.12	402.88	-36.91	-846.92	-710.99	198.61
Shareholders' Equity	27,903	25,795	22,647	20,029	17,876	13,044
Total Liabilities & Equity	31,672	33,039	30,002	27,160	20,792	19,575
Total Debt	119.67	4,304	4,378	3,828	92.75	9.44
Net Cash (Debt)	23,378	20,580	17,253	15,114	13,634	14,589
Net Cash Growth	23.16%	19.29%	14.15%	10.86%	-6.55%	317.24%
Net Cash Per Share	3.88	3.42	2.91	2.52	2.32	2.66
Filing Date Shares Outstanding	5,934	5,924	5,920	5,918	5,919	5,789
Total Common Shares Outstanding	5,934	5,924	5,920	5,918	5,919	5,789
Working Capital	23,974	22,020	23,212	20,156	14,596	11,208
Book Value Per Share	4.70	4.35	3.83	3.38	3.02	2.25
Tangible Book Value	27,707	25,617	22,614	20,012	17,866	13,040
Tangible Book Value Per Share	4.67	4.32	3.82	3.38	3.02	2.25
Buildings	-	2,324	2,311	2,279	1,325	1,201
Machinery	-	2,268	2,130	1,793	1,484	1,222
Construction In Progress	-	367.12	358.52	501.69	347.73	234.82
Leasehold Improvements	-	48.1	41.25	10.9	9.93	7.49

Source: S&P Capital IQ. Standard template. Financial Sources.